Leah Ellis
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa.
Journal: Open forum infectious diseases
Published: August 05, 2022
Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials.
Journal: Frontiers in medicine
Published: April 13, 2022
Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection.
Journal: The Journal of antimicrobial chemotherapy
Published: March 07, 2022
Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.
Journal: Open forum infectious diseases
Published: February 11, 2022
Barriers to Worldwide Access for Paxlovid, a New Treatment for COVID-19.
Journal: Open forum infectious diseases
Published: December 30, 2021
Ivermectin for the prevention of COVID-19: addressing potential bias and medical fraud.
Journal: The Journal of antimicrobial chemotherapy
Published: November 17, 2021
RETRACTED: Expression of Concern: "Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection".
Journal: Open forum infectious diseases
Published: August 19, 2021
Minimum Manufacturing Costs, National Prices, and Estimated Global Availability of New Repurposed Therapies for Coronavirus Disease 2019.
Journal: Open forum infectious diseases
Published: July 17, 2021
Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.
Journal: Open forum infectious diseases
Published: January 20, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026